Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erratum for the Research Article: "Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy" by M. Mayoux, A. Roller, V. Pulko, S. Sammicheli, S. Chen, E. Sum, C. Jost, M. F. Fransen, R. B. Buser, M. Kowanetz, K. Rommel, I. Matos, S. Colombetti, A. Belousov, V. Karanikas, F. Ossendorp, P. S. Hegde, D. S. Chen, P. Umana, M. Perro, C. Klein, W. Xu.

Literature DB >> 32493789

Erratum for the Research Article: "Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy" by M. Mayoux, A. Roller, V. Pulko, S. Sammicheli, S. Chen, E. Sum, C. Jost, M. F. Fransen, R. B. Buser, M. Kowanetz, K. Rommel, I. Matos, S. Colombetti, A. Belousov, V. Karanikas, F. Ossendorp, P. S. Hegde, D. S. Chen, P. Umana, M. Perro, C. Klein, W. Xu.

Abstract

Entities: Disease

Year: 2020 PMID： 32493789 DOI： 10.1126/scitranslmed.abd0088

Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956

Keyword Cloud
Cited

× No keyword cloud information.

4 in total

1. Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

Authors: Tania Afroj; Atsushi Mitsuhashi; Hirokazu Ogino; Atsuro Saijo; Kenji Otsuka; Hiroto Yoneda; Makoto Tobiume; Na Thi Nguyen; Hisatsugu Goto; Kazuya Koyama; Masamichi Sugimoto; Osamu Kondoh; Hiroshi Nokihara; Yasuhiko Nishioka
Journal: J Immunol Date: 2021-01-27 Impact factor: 5.422

2. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1⁺ CD8⁺ T cells in tumor-draining lymph nodes.

Authors: Jason M Schenkel; Rebecca H Herbst; David Canner; Amy Li; Michelle Hillman; Sean-Luc Shanahan; Grace Gibbons; Olivia C Smith; Jonathan Y Kim; Peter Westcott; William L Hwang; William A Freed-Pastor; George Eng; Michael S Cuoco; Patricia Rogers; Jin K Park; Megan L Burger; Orit Rozenblatt-Rosen; Le Cong; Kristen E Pauken; Aviv Regev; Tyler Jacks
Journal: Immunity Date: 2021-09-16 Impact factor: 43.474

3. Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.

Authors: Christopher S Garris; Jeffrey L Wong; Jeffrey V Ravetch; David A Knorr
Journal: Sci Transl Med Date: 2021-05-19 Impact factor: 17.956

4. Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells.

Authors: Renpeng Ding; Shang Liu; Shanshan Wang; Huanyi Chen; Fei Wang; Qumiao Xu; Linnan Zhu; Xuan Dong; Ying Gu; Xiuqing Zhang; Cheng-Chi Chao; Qianqian Gao
Journal: Theranostics Date: 2021-03-05 Impact factor: 11.556

4 in total

1. Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

2. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes.

3. Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.

4. Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells.

2. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1⁺ CD8⁺ T cells in tumor-draining lymph nodes.